Jose G. Bazan

NRG-BR002: A phase IIR/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557).

Steven J. Chmura, Kathryn Winter, Wendy A. Woodward et al. · Journal of Clinical Oncology · 2022 · 188 citations

Surgical Oncology, Breast Oncology, Cancer Management +19

Intensity‐modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal

Jose G. Bazan, Wendy Hara, Annie Hsu et al. · Cancer · 2011 · 149 citations · Full text

Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline

Simona F. Shaitelman, Bethany Anderson, Douglas W. Arthur et al. · Practical Radiation Oncology · 2023 · 146 citations

Breast Oncology, Radiation Therapy, Medicine +9

Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Treated With Intensity-Modulated Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal

Jose G. Bazan, Gary Luxton, Edward C. Mok et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 100 citations

Adaptive Radiotherapy, Acute Hematologic Toxicity, Surgical Oncology +11

Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases

S.J. Chmura, Kathryn Winter, Clifford G. Robinson et al. · JAMA Oncology · 2021 · 99 citations · Full text